Notification
No new Notification messages
Afcons Infrastructure IPO is Open!
Apply for the Afcons Infrastructure IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
indo us bio-tech limited stock

Indo US Bio-Tech Limited Share Price

227.25 -1.85 (-0.80%)
Oct 25 2024 03:30 PM Miscellaneous NSE: INDOUS

Indo US Bio-Tech Limited Share Price Update

As of the latest trading session, Indo US Bio-Tech Limited share price is currently at 227.25, which is down by -1.85 from its previous closing. Today, the stock has fluctuated between 225.05 and 237.95. Over the past year, Indo US Bio-Tech Limited has achieved a return of 0.00 %. In the last month alone, the return has been -21.70 %. Read More...

Indo US Bio-Tech Limited Performance

Day Range

Low225.05 High237.95
227.25

52 Week Range

Low 222.00 High 331.80
227.25

Indo US Bio-Tech Limited Share Price

25503

541304

INDOUS

img img img img
No Data Available

Open Price

234.95

Prev. Close

229.10

Volume (Shares)

8248.00

Total traded value

18.74

Upper Circuit

274.90

Lower Circuit

183.30

Note: The current prices & values are delayed, Login to your account for live updates.

Indo US Bio-Tech Limited Fundamentals


(Standalone)

Market Cap (Cr) 208.31
PE Ratio (TTM) 35.73
Book Value / Share 31.29
Beta 2.28
ROE 14.07%
EPS (TTM) 6.35
Dividend Yield 0.00%
Net Profit Qtr (Cr) 3.17

Indo US Bio-Tech Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 24.72
Operating Expense 21.56
Net Profit 3.17
Net Profit Margin (%) 12.82
Earnings Per Share (EPS) 1.58
EBITDA 3.72
Effective Tax Rate (%) 0.62
Particulars MAR 2024 (Values in Cr)
Revenue 37.88
Operating Expense 33.79
Net Profit 4.21
Net Profit Margin (%) 11.11
Earnings Per Share (EPS) 2.10
EBITDA 5.49
Effective Tax Rate (%) 3.88
Particulars DEC 2023 (Values in Cr)
Revenue 22.11
Operating Expense 18.43
Net Profit 3.68
Net Profit Margin (%) 16.64
Earnings Per Share (EPS) 1.84
EBITDA 4.31
Effective Tax Rate (%) 1.86
Particulars SEP 2023 (Values in Cr)
Revenue 15.81
Operating Expense 13.84
Net Profit 1.67
Net Profit Margin (%) 10.56
Earnings Per Share (EPS) 0.83
EBITDA 2.59
Effective Tax Rate (%) 15.22
Particulars JUN 2023 (Values in Cr)
Revenue 19.14
Operating Expense 16.72
Net Profit 2.37
Net Profit Margin (%) 12.38
Earnings Per Share (EPS) 2.37
EBITDA 3.02
Effective Tax Rate (%) 2.85
Particulars MAR 2024 (Values in Cr)
Revenue 72.84
Operating Expense 64.35
Net Profit 8.25
Net Profit Margin (%) 11.32
Earnings Per Share (EPS) 4.11
EBITDA 11.11
Effective Tax Rate (%) 6.25
Particulars MAR 2023 (Values in Cr)
Revenue 61.74
Operating Expense 54.37
Net Profit 7.24
Net Profit Margin (%) 11.72
Earnings Per Share (EPS) 7.51
EBITDA 9.40
Effective Tax Rate (%) 2.02
Particulars MAR 2022 (Values in Cr)
Revenue 50.05
Operating Expense 44.75
Net Profit 5.27
Net Profit Margin (%) 10.52
Earnings Per Share (EPS) 5.75
EBITDA 7.11
Effective Tax Rate (%) 4.00
Particulars MAR 2021 (Values in Cr)
Revenue 40.09
Operating Expense 36.00
Net Profit 5.10
Net Profit Margin (%) 12.72
Earnings Per Share (EPS) 8.40
EBITDA 5.55
Effective Tax Rate (%) -23.48
Particulars MAR 2020 (Values in Cr)
Revenue 39.76
Operating Expense 36.89
Net Profit 2.53
Net Profit Margin (%) 6.36
Earnings Per Share (EPS) 4.18
EBITDA 3.96
Effective Tax Rate (%) 11.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.01
ROE % 16.91
ROCE % 15.11
Total Debt to Total Equity 0.41
EBITDA Margin 13.92
Particulars MAR 2021 (Values in Cr)
Book Value / Share 35.17
ROE % 25.94
ROCE % 17.20
Total Debt to Total Equity 0.53
EBITDA Margin 13.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.10
ROE % 15.39
ROCE % 14.56
Total Debt to Total Equity 0.52
EBITDA Margin 9.98
Particulars MAR 2024 (Values in Cr)
Book Value / Share 31.29
ROE % 14.07
ROCE % 14.18
Total Debt to Total Equity 0.22
EBITDA Margin 15.27
Particulars MAR 2023 (Values in Cr)
Book Value / Share 54.35
ROE % 15.51
ROCE % 14.37
Total Debt to Total Equity 0.26
EBITDA Margin 15.24
Particulars MAR 2022 (Values in Cr)
Book Value / Share 42.41
ROE % 17.35
ROCE % 15.50
Total Debt to Total Equity 0.40
EBITDA Margin 14.25
Particulars MAR 2021 (Values in Cr)
Book Value / Share 35.50
ROE % 26.86
ROCE % 17.85
Total Debt to Total Equity 0.53
EBITDA Margin 13.89
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27.10
ROE % 16.68
ROCE % 16.13
Total Debt to Total Equity 0.49
EBITDA Margin 9.98
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 55.61
Total Liabilities 55.61
Total Equity 38.50
Share Outstanding 9166700
Price to Book Ratio 1.59
Return on Assets (%) 9.10
Return on Capital (%) 9.86
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 43.70
Total Liabilities 43.70
Total Equity 21.34
Share Outstanding 6067990
Price to Book Ratio 0.92
Return on Assets (%) 11.21
Return on Capital (%) 14.89
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 34.69
Total Liabilities 34.69
Total Equity 16.44
Share Outstanding 6067990
Price to Book Ratio 1.89
Return on Assets (%) 7.30
Return on Capital (%) 10.43
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.09
Total Assets 84.45
Total Liabilities 84.45
Total Equity 62.74
Share Outstanding 20052000
Price to Book Ratio 7.09
Return on Assets (%) 9.77
Return on Capital (%) 10.71
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.18
Total Assets 69.46
Total Liabilities 69.46
Total Equity 54.49
Share Outstanding 10026000
Price to Book Ratio 3.91
Return on Assets (%) 10.42
Return on Capital (%) 10.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 55.57
Total Liabilities 55.57
Total Equity 38.87
Share Outstanding 9166700
Price to Book Ratio 1.59
Return on Assets (%) 9.42
Return on Capital (%) 10.19
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 43.67
Total Liabilities 43.67
Total Equity 21.54
Share Outstanding 6067990
Price to Book Ratio 0.92
Return on Assets (%) 11.67
Return on Capital (%) 15.44
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 34.69
Total Liabilities 34.69
Total Equity 16.44
Share Outstanding 6067990
Price to Book Ratio 1.89
Return on Assets (%) 7.30
Return on Capital (%) 10.43
Particulars MAR 2022 (Values in Cr)
Net Income 5.31
Cash from Operations 3.08
Cash from Investing -5.44
Cash from Financing 2.65
Net change in Cash -0.08
Free Cash Flow 7.05
Particulars MAR 2021 (Values in Cr)
Net Income 3.92
Cash from Operations 0.29
Cash from Investing -1.77
Cash from Financing 1.55
Net change in Cash -0.06
Free Cash Flow 2.24
Particulars MAR 2020 (Values in Cr)
Net Income 2.86
Cash from Operations -0.81
Cash from Investing -0.56
Cash from Financing 1.52
Net change in Cash 0.11
Free Cash Flow -0.41
Particulars MAR 2024 (Values in Cr)
Net Income 8.80
Cash from Operations -4.27
Cash from Investing 4.27
Cash from Financing 1.21
Net change in Cash 0.90
Free Cash Flow -1.66
Particulars MAR 2023 (Values in Cr)
Net Income 7.38
Cash from Operations 0.84
Cash from Investing -6.67
Cash from Financing 6.28
Net change in Cash 0.14
Free Cash Flow 2.66
Particulars MAR 2022 (Values in Cr)
Net Income 5.48
Cash from Operations 3.29
Cash from Investing -5.40
Cash from Financing 2.41
Net change in Cash -0.08
Free Cash Flow 7.26
Particulars MAR 2021 (Values in Cr)
Net Income 4.12
Cash from Operations 0.36
Cash from Investing -1.75
Cash from Financing 1.46
Net change in Cash -0.06
Free Cash Flow 2.27
Particulars MAR 2020 (Values in Cr)
Net Income 2.86
Cash from Operations -0.81
Cash from Investing -0.56
Cash from Financing 1.52
Net change in Cash 0.11
Free Cash Flow -0.41
Company Name Price P/E P/B Market Cap 52 Week Low/High
Atlas Cycles (Haryana) Ltd 29.00 0.00 -0.59 18.86 0.00 / 0.00
Jaykay Enterprises Limited 125.54 115.17 4.51 1467.76 42.87 / 166.19
MODI RUBBER LTD 127.10 17.01 0.62 318.26 80.11 / 156.75
THOMAS COOK (INDIA) LTD 183.55 33.07 5.81 8643.01 113.00 / 264.00
RAIN INDUSTRIES LIMITED 157.65 0.00 0.74 5302.56 130.20 / 219.65
Company Name Price P/E P/B Market Cap 52 Week Low/High
Atlas Cycles (Haryana) Ltd 29.00 31.87 -0.59 18.86 0.00 / 0.00
FGP LTD. 10.99 24.42 3.51 13.08 5.21 / 14.18
Jaykay Enterprises Limited 125.54 78.96 4.77 1467.76 42.87 / 166.19
MPIL CORPORATION LTD. 676.00 0.00 2.59 38.53 506.00 / 1264.05

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 242.90
  • 26 Days 268.00
  • 10 Days 251.00
  • 50 Days 277.30
  • 12 Days 253.00
  • 100 Days 284.10
  • 20 Days 263.80
  • 200 Days 292.10
231.00
PIVOT
First Resistance 237.10
Second Resistance 245.10
Third Resistance 251.20
First Support 223.00
Second Support 216.90
Third Support 208.90
RSI 16.13
MACD -15.09
Commodity Channel Index (CCI) -177.08
ADX 62.48
Williams % R -89.51

Over 1 Month

down

-21.70

Over 3 Months

down

0.00

Over 6 Months

down

0.00

Over 1 Year

down

0.00

Over 3 Years

down

0.00

Over 5 Years

down

0.00

Indo US Bio-Tech Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Indo US Bio-Tech Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
29.82
Promoter Holdings
70.17
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Jagdishkumar Devjibhai Ajudiya Shareholding of Promoter and Promoter Group 9788924.0 48.82
Indo Us Agriseeds Limited Shareholding of Promoter and Promoter Group 2146824.0 10.71
Ajudia Jagdish Devjibhai Huf Shareholding of Promoter and Promoter Group 1150028.0 5.74
Malti Jagdishbhai Ajudia Shareholding of Promoter and Promoter Group 584122.0 2.91
Priyanka Jagdishbhai Ajudia Shareholding of Promoter and Promoter Group 400000.0 1.99
Improwised Technologies Private Public Shareholding 400000.0 1.99
Pratik Rajendrabhai Gandhi Public Shareholding 300000.0 1.5
Aumit Capital Advisors Limited Public Shareholding 237000.0 1.18
Natvarsinh T Chavda . Public Shareholding 221000.0 1.1
Nitin Dalpatlal Shah Public Shareholding 213300.0 1.06
Samarth Nileshbhai Patel Shareholding of Promoter and Promoter Group 500.0 0.0
Hinaben Nileshbhai Patel Shareholding of Promoter and Promoter Group 500.0 0.0

Indo US Bio-Tech Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2021-10-28 0.25 Interim 2021-10-29 Equity shares
Ex-Date Ex-Bonus Ratio
2023-08-29 2023-08-29 1:1 2021-11-30 2021-11-29 1:5 2019-04-24 2019-04-23 1:4
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About Indo US Bio-Tech Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Indo US Bio-Tech Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Indo US Bio-Tech Ltd?

Answer Field

The share price of Indo US Bio-Tech Ltd for NSE is ₹ 227.25 and for BSE is ₹ 237.45.

What is the Market Cap of Indo US Bio-Tech Ltd?

Answer Field

The market cap of Indo US Bio-Tech Ltd for NSE is ₹ 2,08.31 Cr. and for BSE is ₹ 2,17.66 Cr. as of now.

What is the 52 Week High and Low of Indo US Bio-Tech Ltd?

Answer Field

The 52 Week High and Low of Indo US Bio-Tech Ltd for NSE is ₹ 331.80 and ₹ 222.00 and for BSE is ₹ 349.80 and ₹ 180.00.

How to Buy Indo US Bio-Tech Ltd share?

Answer Field

You can trade in Indo US Bio-Tech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Indo US Bio-Tech Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the Current Share Price of Indo US Bio-Tech Ltd?

Answer Field

Indo US Bio-Tech Ltd share price is for NSE ₹ 227.25 & for BSE ₹ 237.45 as on Oct 25 2024 03:30 PM.

What is the Market Cap of Indo US Bio-Tech Ltd Share?

Answer Field

The market cap of Indo US Bio-Tech Ltd for NSE ₹ 2,08.31 & for BSE ₹ 2,17.66 as on Oct 25 2024 03:30 PM.

What is the P/E Ratio of Indo US Bio-Tech Ltd Share?

Answer Field

As on Oct 25 2024 03:30 PM the price-to-earnings (PE) ratio for Indo US Bio-Tech Ltd share is 35.73.

What is the PB ratio of Indo US Bio-Tech Ltd Share?

Answer Field

As on Oct 25 2024 03:30 PM, the price-to-book (PB) ratio for Indo US Bio-Tech Ltd share is 31.29.

How to Buy Indo US Bio-Tech Ltd Share?

Answer Field

You can trade in Indo US Bio-Tech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Indo US Bio-Tech Ltd Share on Bajaj Broking App?

Answer Field

To buy Indo US Bio-Tech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Indo US Bio-Tech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader